Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00515424 | Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension | PHASE1 | COMPLETED | 90 | — | — | Jul 1, 2007 | - | Dec 28, 2007 | 5 | United States |
| Name | Type | Description |
|---|---|---|
| RKI983 | DRUG | - |
Inclusion Criteria: * Males and females, ≥18 years of age, with primary open angle glaucoma and ocular hypertension * Females must be post-menopausal or surgically sterile Exclusion Criteria: * Other types of glaucoma * Eye pressure lowering surgeries * A history of or current eye conditions or m...